INTRODUCTION
Fatty liver diseases (FLD) is abnormal accumulation of fat mainly triglycerides in the Hepatocytes. It is a reversible condition. It is considered as single diseases and had multiple causes including excess alcohol and obese individuals (with or without insulin resistance). There is a relationship between FLD and other diseases that influence fat metabolism [1].
Non-alcoholic fatty liver disease (NAFLD) is one of the reasons of a fatty liver, occurring when fat is deposited in the liver due to causes other than excessive alcohol use [2] .
NAFLD is considered as a hepatic manifestation of metabolic disorder (MD), and patients with NAFLD often have one or more components of the MD such as obesity, dyslipidemia, hypertension, and raised fasting plasma glucose levels or overt type 2 diabetes mellitus (T2DM) [3] .
NAFLD may present as simple hepatic steatosis or steatohepatitis in which there is damage of hepatocytes together with inflammatory process in the liver secondary to oxidative stress caused by excess fat accumulation. It may end in fibrosis and cirrhosis and almost identical to those of alcoholic liver diseases [4] .
Obesity, hyperlipidemia and T2DM are existing together conditions that frequently associate non-alcoholic fatty liver disease. The prevalence of obesity in several patients with non-alcoholic fatty liver disease ranged between (30-100%), the prevalence of T2DM ranged 
PATIENTS AND METHODS

Study design and settings
Inclusion and Exclusion criteria
Patients with elevated liver enzymes and bright liver by ultrasonography were examined and investigated for selection of patients with nonalcoholic steatohepatitis which was proved by liver biopsy and healthy subjects of matched age and sex were included as a control group. While patients who had history of alcohol consumption, positive hepatitis B and C virus markers, history of statin drug intake and any other metabolic or autoimmune liver diseases were excluded.
Methods and study tools:
Control and patient groups were subjected to: Grade III: Marked increase in the fine echoes. Poor or no visualization of intrahepatic vessels and diaphragm and poor penetration of the posterior, segment of the right lobe of the liver.
 Liver biopsy Technique [10] Liver biopsy was done only for patient group using a semiautomatic true cut needle 16 gauge after taking informed consent and assessment of prothrombin time and platelet count. Patient was brought into the equipped room, he was asked to lay on his back with the right arm up behind his neck to expose the right side of the body. After marking of the skin, an antiseptic was applied, the patient was given an intravenous sedation. A local anesthetic like xylocaine was also used at the biopsy site. A small cut was made in the skin about 5mm long to let the needle pass through more easily, where the biopsy needle was passed through to the liver and the sample was taken and was put in formalin for histopathological examination. Occasionally the biopsy was too small and in these cases, it was needed to pass the needle a second or a third time. The required time to stay in bed was four hours after the procedure. The patient was instructed to lay on this side immediately after the procedure and after one hour he can sit up slightly.
Statistical analysis
Data were checked, entered and analyzed using SPSS 22 for Windows (SPSS Inc., Chicago, IL, USA). Data were expressed as mean ± SD for quantitative variable, number and percentage for qualitative one. Chi-squared (X 2 ) or t test and paired t test were used when appropriate. P<0.05 was considered significant. P<0.001 was considered high significant.
RESULTS
BMI was significantly higher among NASH group when compared to control group. (Table  1 ). There was a significant difference as regard ALT & AST in NASH group in comparison with control group. (Table2). There was a significant difference as regard triglycerides, total cholesterol, LDL & HDL in NASH group in comparison with control group (Table 3) . There was a significant difference as regard fasting blood glucose, post prandial blood glucose, insulin & HOMA-IR in NASH group in comparison with control group (Table 4) . There was a significant difference as regard serum resistin in NASH group in comparison with control group (Table 5) . A positive correlation in NASH group between serum resistin and the following parameters: age, BMI, ALT, AST, TGs, Cholesterol, LDL, Fasting and postprandial blood glucose, insulin and HOMA-IR (Table 6 ). Cutoff value of serum resistin was >3.7 ng/ml (Table 7) . 
DISCUSSION
NAFLD is one of the reasons of a fatty liver occurring when fat is deposited in the liver due to causes other than excessive alcohol use [2] while Non-Alcoholic steatohepatitis is a subgroup of NAFLD patients which characterized by damage to and inflammation of hepatocytes in addition to excessive fat steatohepatitis. NASH is practically indistinguishable histologically from alcoholic steatohepatitis and is characterized by fatty infiltration of the liver with different degrees of inflammation, necrosis, and fibrosis, almost identical to those of alcoholic liver disease [4] . Resistin is a polypeptide particularly emitted from adipocytes and its serum concentration rising is usually associated with obesity [3]. This study was aimed to determine the importance of resistin as a diagnostic marker for NASH.
Our participants age and sex were matched but a significant difference regarding BMI (kg/m 2 ) was found between the two studied groups with mean ± SD (23.46 ± 0.76) in control group and mean ± SD (32.71 ± 1.18 kg/m 2 ) in patient group.
We reported a significant difference in serum level of both ALT (25.63 ± 7.58 U/L) and (83 ± 10.86 U/L), and AST (16.57 ± 4.92 U/L) and (56.68 ± 7.33 U/L) in control group and patient group respectively. These results agree with those of Pagano et al.
[12] who found significant difference between the NAFLD group, that was sub classified to pure fatty liver and NASH, and control group. Also, Shen et al.
[13] reported the same finding, however, there was no significant difference between the two groups as regard total protein, albumin, total bilirubin, direct bilirubin, PT and INR in this study.
In our study, triglycerides showed a significant difference in comparison between the two groups the mean ± SD of control group was (112. [12] was (27.3 ± 0.6).
A positive correlation also was found in our study in NASH group between serum resistin and serum ALT and AST, serum triglycerides, serum cholesterol and serum LDL. This was reported and confirmed by Mohamed et al. [15] .
The positive correlation that was reported in our study in NASH patients between serum resistin, and both fasting and postprandial blood glucose were supported and enforced by results obtained by both Lu et 
